Xeris Biopharma Holdings, Inc. (XERS)
5.44
-0.02
(-0.37%)
USD |
NASDAQ |
Mar 16, 15:09
Xeris Biopharma Holdings EPS Diluted (Quarterly) : 0.0615 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1994 |
| Zoetis, Inc. | 1.375 |
| Harrow, Inc. | 0.178 |
| Zymeworks, Inc. | -0.547 |
| Vir Biotechnology, Inc. | -0.3083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.08M |
| Revenue (Quarterly) | 85.81M |
| Total Expenses (Quarterly) | 74.73M |
| Enterprise Value | 1.089B |
| Gross Profit Margin (Quarterly) | 84.08% |
| Profit Margin (Quarterly) | 12.91% |
| Earnings Yield | -0.14% |
| Operating Earnings Yield | 2.73% |
| Normalized Earnings Yield | -0.1379 |